1. Home
  2. ABSI vs BFLY Comparison

ABSI vs BFLY Comparison

Compare ABSI & BFLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Absci Corporation

ABSI

Absci Corporation

HOLD

Current Price

$8.22

Market Cap

997.8M

Sector

Health Care

ML Signal

HOLD

Logo Butterfly Network Inc.

BFLY

Butterfly Network Inc.

HOLD

Current Price

$6.54

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABSI
BFLY
Founded
2011
2011
Country
United States
United States
Employees
N/A
220
Industry
Biotechnology: Pharmaceutical Preparations
Medical Electronics
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
997.8M
1.2B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ABSI
BFLY
Price
$8.22
$6.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$6.96
$5.00
AVG Volume (30 Days)
7.7M
12.2M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
10.64
N/A
EPS
N/A
N/A
Revenue
$4,534,000.00
N/A
Revenue This Year
$215.96
$24.01
Revenue Next Year
$319.10
$19.93
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.24
$1.32
52 Week High
$12.06
$9.69

Technical Indicators

Market Signals
Indicator
ABSI
BFLY
Relative Strength Index (RSI) 42.86 45.09
Support Level $2.56 $3.83
Resistance Level $12.06 $9.58
Average True Range (ATR) 0.76 0.64
MACD -0.49 -0.27
Stochastic Oscillator 14.93 7.19

Price Performance

Historical Comparison
ABSI
BFLY

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

About BFLY Butterfly Network Inc.

Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.

Share on Social Networks: